Cabahug, Melogie .

HRN: 03-07-41  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2023
AMPICILLIN 1GM (VIAL)
12/28/2023
12/31/2023
IV
2 G
Q6
PROM
Waiting Final Action 
12/29/2023
CO-AMOXICLAV 625MG (TAB)
12/29/2023
01/05/2024
PO
500
BID
3rd Degree RMLE
Waiting Final Action 
12/29/2023
CO-AMOXICLAV 625MG (TAB)
12/29/2023
01/04/2024
PO
1tab
TID
Rmle 3rd Degree
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: